Renewed supplement probe after anaphylaxis reports

The medicines watchdog is looking at whether a cold and flu supplement should keep its ‘low-risk ingredient’ designation after its reported links to severe allergies The Therapeutic Goods Administration (TGA) is asking for opinions on the safety profile of a popular cold and flu herbal medicine sold in pharmacies, which has been linked to a